Tissue engineering (TE) has provided promising strategies for regenerating tissue defects,
but few TE approaches have been translated for clinical applications. One major barrier in …

This review focuses on phase‐shift perfluorocarbon nanoemulsions whose action depends
on an ultrasound‐triggered phase shift from a liquid to gas state. For drug‐loaded …

Tumor hypoxia is known to be one of critical reasons that limit the efficacy of cancer
therapies, particularly photodynamic therapy (PDT) and radiotherapy (RT) in which oxygen …

Perfluorocarbon nanoemulsions can deliver lipophilic therapeutic agents to solid tumors and
simultaneously provide for monitoring nanocarrier biodistribution via ultrasonography and/or …

Pancreatic ductal adenocarcinoma (PDAC) exhibits difficult penetration of most drugs,
leading to a very poor therapeutic outcome with a quite low five-year survival rate. The …

Blood transfusion is oftentimes required for patients suffering from acute trauma or
undergoing surgical procedures in order to help maintain the body's oxygen levels. The …

Blood transfusion is the key to life in case of traumatic emergencies, surgeries and in several
pathological conditions. An important goal of whole blood or red blood cell transfusion is the …

Micron-sized liquid perfluorocarbon (PFC) droplets are currently being investigated as
activatable agents for medical imaging and cancer therapy. After injection into the …

-The use of restrictive transfusion strategies in nonbleeding, euvolaemic anaemic patients.-
Perioperative administration of tranexamic acid to patients undergoing cardiac surgery.-The …

The interaction of nanoparticles with directed energy is a novel application in targeted drug
delivery. This chapter focuses on perfluorocarbon nanoemulsions, whose action in drug …